MANE · Veradermics, Inc · Webcasts, Transcripts & Audio
$124.39
-0.47 (-0.38%)
At close · Nov 19
Return incl. dividend (before tax)
Market Cap
$5.25B
Shares
42.20M
Volume · Nov 19
293.74K
Avg daily vol (3M)
739.62K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Veradermics, Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Veradermics, Inc (MANE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-19
Veradermics, Inc (MANE) November 19, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Investor Update
Investor event
2026-11-10
Veradermics, Inc (MANE) November 10, 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Investor Update
Investor event
2026-11-09
Veradermics, Inc (MANE) November 9, 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-19
Veradermics, Inc (MANE) Q3 2026 Earnings Call
Diluted EPS
$-0.50
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-15
Veradermics, Inc (MANE) Q2 2026 Earnings Call
Confident tone
Study 207 female Phase II results
Pivotal trial outlook (Study 306)
VDPHL01 product profile (extended-release oral minoxidil)
Diluted EPS
$-0.58
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Veradermics, Inc (MANE) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Veradermics, Inc (MANE) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-04-27
Veradermics, Inc (MANE) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–8 of 8 webcasts
Key facts
CIK
1827635
CUSIP
922967104
13F (30d)
201 filings
198 filers
Visit website
Investor relations